期刊文献+

泛素-蛋白酶体抑制剂对大鼠肺纤维化的影响 被引量:2

Effects of ubiquitin-proteasome inhibitor MG-132 on bleomycin induced pulmonary fibrosis in rats
原文传递
导出
摘要 目的:探讨泛素-蛋白酶体抑制剂MG-132对大鼠肺纤维化的影响。方法:45只SD大鼠随机分成对照组、模型组、干预组和治疗组。模型组和干预、治疗组大鼠气管内滴入博来霉素(5mg.kg-1)建立肺纤维化动物模型,对照组以等量生理盐水气管内滴入。干预组于第造模后第1天起给予MG-132腹腔内注射(0.1mg.kg-1.d-1),模型组和对照组注射等量生理盐水;治疗组于造模后第28天起给予MG-132(0.1mg.kg-1.d-1)腹腔内注射。于不同时间点测肺系数、肺组织行病理学检查及肺组织羟脯氨酸(HYP)含量测定。结果:干预组及治疗组肺系数及肺组织HYP含量各时间点均低于模型组(P<0.01,P<0.05),肺泡炎的程度也轻于模型组;虽然干预组和治疗组肺纤维化程度均明显重于对照组,但干预组28d和治疗组肺纤维化较模型组轻。结论:泛素-蛋白酶体抑制剂MG-132对大鼠肺纤维化有一定的干预、治疗作用。 OBJECTIVE To investigate the effects of ubiquitin-proteasome inhibitor MG-132 on pulmonary fibrosis in rats. METHODS 45 male SD rats were randomly divided into four groups~ control group, model group, intervention group and treatment group. The model group, intervention group and treatment group were intratracheally instilled with bleomycin (5 mg·kg 1), the control group were subjected to equivalent saline. The intervention group were intraperitoneally injected with MG- 132 (0. 1 mg·kg-1· d-1 ) from the first day after intratraeheal instillation, the model group and control group were intraperitoneally injected with equivalent saline. The treatment group were intraperitoneally injected with MG-132 (0. 1 mg· kg-1·d l ) from 28th day after intratracheal instillation. The lung coefficient, lung pathological manifestations and level of hydroxyproline (HYP) in lung tissue were evaluated at different time points in each group, RESULTS The lung coefficient and level of HYP and in intervention group and treatment group were all lower than those of model group significantly(P〈0. 01, P〈0, 05), also the same of degree of alveolitis;although the degree of lung fibrosis in intervention group and model group and treatment group were all more severe than those of control group,whereas the degree of lung fibrosis in intervention group at 28th day and treatment group were lessened compared with those of model group, CONCLUSION Ubiquitin-proteasome inhibitor MG-132 can prevent and reduce pulmonary fibrosis to some degree in rats.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第3期196-198,共3页 Chinese Journal of Hospital Pharmacy
基金 湖北省卫生厅自然科学基金一般项目(课题号:JX5B58)
关键词 泛素-蛋白酶体抑制剂 肺纤维化 ubiquitin-proteasome inhibitor pulmonary fibrosis
  • 相关文献

参考文献10

  • 1Gribbin J,Hubbard RB,LeJeune I. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK[J].Thorax,2006,(11):980-985.
  • 2韩琳(综述),王伟铭(审校),陈楠(审校).蛋白酶体抑制剂与肾间质纤维化[J].国际泌尿系统杂志,2008,28(2):244-248. 被引量:1
  • 3Meiners S,Hocher B,Weller A. Downregulation of ma trix metallo proteinases and collagens and suppression of cardiac fibrosis by in-ihibition of the proteasome[J].Hypertension,2004,(04):471-477.
  • 4Szapiel SV,Elson NA,Fulmer JD. Bleomycin induced interstitial pulmonary disease in zhe nude,athymic mouse[J].American Review of Respiratory Diseases,1979,(04):893.
  • 5Kisseleva T,Brenner DA. Mechanisms of Fibrogenesis[J].Experimental Biology and Medicine,2008,(02):109-122.
  • 6Hardie WD,Glasser SW,Hagood JS. Emerging Concepts in the Pathogenesis of Lung Fibrosis[J].American Journal of Pathology,2009.3-16.
  • 7Doherty FJ,Dawson S,Mayer RJ. The ubiquitin-proteasome pathway of intracellular proteolysis[J].Essys Biochem,2002.51-63.
  • 8Anan A,Baskin-Bey ES,Bronk SF. Proteasome inhibition induces hepatic stellate cell apoptosis[J].Hepatology,2006,(02):335-344.
  • 9韩琳,陈慧,朱冰冰,靳远萌,王伟铭,陈楠.蛋白酶体抑制剂抑制肾间质成纤维细胞细胞外基质表达及其机制[J].肾脏病与透析肾移植杂志,2008,17(5):439-445. 被引量:5
  • 10赵丹丹,李奕萍,刘谊.蛋白酶体抑制剂MG132诱导细胞凋亡机制的研究进展[J].华西医学,2008,23(3):633-634. 被引量:8

二级参考文献28

共引文献11

同被引文献17

  • 1Franck Verrecchia,Alain Mauviel.Transforming growth factor-β and fibrosis[J].World Journal of Gastroenterology,2007,13(22):3056-3062. 被引量:114
  • 2Javelaud D, Mauvie A. Mammalian transforming growth factor-βs: Smad signaling and physio-pathological roles [J]. Int J Biochem Cell Biol, 2004, 36(7) :1161-1165.
  • 3Krakowski AR, Laboreau J, Mauviel A, et al. Cytoplas- mic SnoN in normal tissue and nomaligant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins [J]. Proc Natl Acad Sci U S A, 2005, 102(35) :12473- 12442.
  • 4Levy L, Howell M, Das D, et al. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal- induced SnoN degradation [ J ]. Mol Cell Biol, 2007, 27 ( 17 ) :6068-6083.
  • 5Tan R, Zhang J, Tan X, et al. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation [ J ]. J Am Soc Nephrol, 2006, 17 (10) :2781-2791.
  • 6Inoue Y, Imamura T. Regulation of TGF-beta family sig- naling by E3 ubiquitin ligases [ J ]. Cancer Sci, 2008, 99 (11) :2107-2112.
  • 7Kodigepalli KM, Dutta PS, Bauckman KA, et al. SnoN/ SkiL expression is modulated via arsenic trioxide-induced activatin of the PI3K/AKT pathway in ovarian cancer cells [J]. FEBSLett, 2012, 587(1) :5-16.
  • 8Kim MK, Maeng YI, Sung WJ, et al. The differential ex- pression of TGF-β1, ILK and wnt signaling inducing epi- thelial to mesenchymal transition in human renal fibrogene- sis: an immunohistochemical study [ J ]. Int J Clin Exp Pathol, 2013, 6(9):1747-1758.
  • 9Meiners S, Hoeher B, Welle A, et al. Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome [ J ]. Hy- pertension, 2004, 44 (4) :471-477.
  • 10Tan R, He W, Lin X, et al. Smad ubiquitination regula- tory factor-2 in the fibrotic kidney: regulation, target spec- ificity, and function implication [ J ]. Am J Physiol Renal Physiol, 2008, 294 (5) : F1076-F1083.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部